Drug Therapy Delayed for Blacks With HIV

Key points
- White doctors routinely delay treatment of HIV-positive black patients, a new finding that adds to a growing body of research that suggests a sharp racial divide in American medical care.
- Researchers didn't examine why doctors act differently when their patients are black, and it's not clear that racism is the cause, said study co-author Dr.
- King and his colleagues examined the results of a previous study that looked at HIV-positive patients from 1996 to 1999.
- The researchers report their findings in the November issue of the Journal of General Internal Medicine.
White doctors routinely delay treatment of HIV-positive black patients, a new finding that adds to a growing body of research that suggests a sharp racial divide in American medical care.
Researchers didn't examine why doctors act differently when their patients are black, and it's not clear that racism is the cause, said study co-author Dr. William D. King, a visiting assistant professor of infectious diseases at the University of California at Los Angeles. However, he said, "we can definitely see there is a huge disparity. There is discrimination."
King and his colleagues examined the results of a previous study that looked at HIV-positive patients from 1996 to 1999. Of 1,241 adult patients, 61 percent were white with white doctors, 32 percent were black with white doctors, and 6 percent were black with black doctors. Fewer than 1 percent were whites with black doctors.
The researchers report their findings in the November issue of the Journal of General Internal Medicine.
Overall, the black patients received powerful HIV drugs after a median of 439 days - well over a year - compared to 277 days for whites. If blacks had white doctors, they received drugs after a median of 461 days; if they had black doctors, the delay was only 342 days. White patients with white doctors, meanwhile, received drugs after 353 days, similar to black patients with black doctors.
The differences between the races remained even when the researchers took into account factors such as how far the cases of HIV had progressed. "Medically, we couldn't really find an explanation about why this disparity existed," King said.
It seems likely the delayed care would have hurt the black patients, although the study didn't examine how their health changed over time. "If they didn't get the medicine in a timely manner, they could have gone to be sicker or died earlier from the disease," King said.
During the years of the initial study, a new generation of drugs began boosting the life spans of AIDS patients, and many of them now are able to live fairly normal lives.
So what's the explanation for the disparity? The researchers suggest there may be a communications divide between blacks and whites that contributes to a lack of trust. "If patients trust you, they're more likely to come back for care and to take the regimens that are prescribed," King said.
The researchers also pointed to previous studies suggesting that white doctors think black patients are more likely to fail to follow instructions about drug regimens.
As for racism, it's difficult to prove because it's hard to define, King said.
Paul D. Cleary, a professor of health care policy at Harvard Medical School, agreed. "Different people define it differently," said Cleary, who studies racial disparities in health care. "A lot of people think of it as an overt, conscious way of treating people of color differently than other people. I think it's subtler than that."
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Infections, HIV & STIs →
NewsStudy examines effect on pregnancy of receiving antiretroviral therapy for preventing HIV
Among heterosexual African couples in which the male was HIV positive and the female was not, receipt of antiretroviral pre-exposure preventive (PrEP) therapy did not result in significant differences in pregnancy…
21 July 2014
News'Expressive therapy" intervention assists women living with HIV
New research from UC San Francisco shows that an "expressive therapy" group intervention conducted by The Medea Project helps women living with HIV disclose their health status and improves their social support,…
12 July 2014
NewsTransplant drugs may help wipe out persistent HIV infections
New research suggests that drugs commonly used to prevent organ rejection after transplantation may also be helpful for combating HIV. The findings, which are published in the American Journal of Transplantation,…


